 |
| 12.10.2015 | AGENDA |
| | . |
| 1:00 – 2:00 | Registration & Networking |
| 2:00 – 2:10 | Welcome & Opening Remarks
Jim Edwards, Publisher, Xconomy
Aarif Khakoo, VP Research and San Francisco Site Head, Amgen |
| 2:10 – 2:30 | Gene Editing: A Pioneer’s View of Its Promises and Perils
Edward Lanphier, President and CEO, Sangamo BioSciences |
| 2:30 – 3:00 | A CRISPR Business: The Caribou-Intellia Story
Andy May, Chief Scientific Officer, Caribou Biosciences and Cofounder, Intellia Therapeutics
Tom Barnes, Chief Scientific Officer, Intellia Therapeutics
Jenny Rooke, Managing Director, 5 Prime Ventures |
| 3:00 – 3:30 | Microbiome Pioneers: Who Can Stomach A Startup?
Colleen Cutcliffe, CEO, Whole Biome
Peter DiLaura, CEO, Second Genome |
| 3:30 – 4:00 | Networking Break |
| 4:00 – 4:15 | Big Data One: Making California Healthier
Atul Butte, Director, Institute of Computational Health Sciences, UCSF |
| 4:15 – 4:30 | Big Data Two: Helix and the Consumer Genome
Justin Kao, SVP of Corporate Development, Operations, and Strategy, Helix |
| 4:30 – 4:45 | Big Data Three: Gene Testing For Everyone
Randy Scott, CEO, Invitae |
| 4:45 – 5:15 | You Will Be Sequenced. Who Will Benefit?
Atul Butte, Director, Institute of Computational Health Sciences, UCSF
Randy Scott, CEO, Invitae
Justin Kao, SVP of Corporate Development, Operations, and Strategy, Helix
Nina Kjellson, General Partner, Canaan Partners (Moderator) |
| 5:15 – 5:45 | Finding The Ethical Line In 21st Century Biology
Hank Greely, Director, Center for Law and the Biosciences, Stanford University
Marcy Darnovsky, Director, Center for Genetics and Society |
| 5:45 – 6:45 | Networking Reception |
